258 related articles for article (PubMed ID: 12923577)
21. Remission of thrombotic thrombocytopenic purpura in a patient with compound heterozygous deficiency of von Willebrand factor-cleaving protease by infusion of solvent/detergent plasma.
Kentouche K; Budde U; Furlan M; Scharfe V; Schneppenheim R; Zintl F
Acta Paediatr; 2002; 91(10):1056-9. PubMed ID: 12434890
[TBL] [Abstract][Full Text] [Related]
22. Immunotherapy for thrombotic thrombocytopenic purpura.
Cataland SR; Wu HM
Curr Opin Hematol; 2005 Sep; 12(5):359-63. PubMed ID: 16093780
[TBL] [Abstract][Full Text] [Related]
23. Thrombotic thrombocytopenic purpura as a rare cause of anemia with thrombocytopenia in childhood: report of 2 cases.
Köker O; Yıldırmak ZY; Genç DB; Kılıçaslan Ö
Turk J Pediatr; 2019; 61(3):418-423. PubMed ID: 31916721
[TBL] [Abstract][Full Text] [Related]
24. [From gene to disease; congenital thrombotic thrombocytopenic purpura due to mutations in the ADAMTS13 gene].
Schiphorst RH; van de Kar NC; van den Heuvel LP
Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2422-4. PubMed ID: 14694551
[TBL] [Abstract][Full Text] [Related]
25. Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP).
Ahmad A; Aggarwal A; Sharma D; Dave HP; Kinsella V; Rick ME; Schechter GP
Am J Hematol; 2004 Oct; 77(2):171-6. PubMed ID: 15389904
[TBL] [Abstract][Full Text] [Related]
26. Inherited ADAMTS13 deficiency: unique presentation and treatment.
Born H; Peters A; Ettinger R
Pediatr Blood Cancer; 2008 May; 50(5):956-7. PubMed ID: 18240172
[TBL] [Abstract][Full Text] [Related]
27. Transfusion medicine illustrated. Massive hemolysis due to thrombotic thrombocytopenic purpura in a patient with AIDS.
Adamski J; Marques MB
Transfusion; 2012 Jul; 52(7):1408-9. PubMed ID: 22780894
[No Abstract] [Full Text] [Related]
28. Cancer-related thrombotic microangiopathy secondary to Von Willebrand factor-cleaving protease deficiency.
Blot E; Decaudin D; Veyradier A; Bardier A; Zagame OL; Pouillart P
Thromb Res; 2002 Apr; 106(2):127-30. PubMed ID: 12182911
[TBL] [Abstract][Full Text] [Related]
29. Thrombotic thrombocytopenic purpura: the systemic clumping "plague".
Moake JL
Annu Rev Med; 2002; 53():75-88. PubMed ID: 11818464
[TBL] [Abstract][Full Text] [Related]
30. Mild to moderate reduction of a von Willebrand factor cleaving protease (ADAMTS-13) in pregnant women with HELLP microangiopathic syndrome.
Lattuada A; Rossi E; Calzarossa C; Candolfi R; Mannucci PM
Haematologica; 2003 Sep; 88(9):1029-34. PubMed ID: 12969811
[TBL] [Abstract][Full Text] [Related]
31. [Thrombotic thrombocytopenic purpura. Reduced activity of von Willebrand factor cleaving protease].
Kunze A; Terborg C; Gerth J; Heide G; Witte OW
Nervenarzt; 2004 Aug; 75(8):785-9. PubMed ID: 15034657
[TBL] [Abstract][Full Text] [Related]
32. Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura.
Bianchi V; Robles R; Alberio L; Furlan M; Lämmle B
Blood; 2002 Jul; 100(2):710-3. PubMed ID: 12091372
[TBL] [Abstract][Full Text] [Related]
33. Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura.
Furlan M; Robles R; Morselli B; Sandoz P; Lämmle B
Thromb Haemost; 1999 Jan; 81(1):8-13. PubMed ID: 10348715
[TBL] [Abstract][Full Text] [Related]
34. Review of thrombotic microangiopathy (TMA), and post-renal transplant TMA.
Ardalan MR
Saudi J Kidney Dis Transpl; 2006 Jun; 17(2):235-44. PubMed ID: 16903637
[TBL] [Abstract][Full Text] [Related]
35. Chronic relapsing thrombotic thrombocytopenic purpura due to a deficiency of von Willebrand factor-cleaving protease activity.
Stark GL; Wallis JP; Allford SL; Hanley J
Br J Haematol; 2002 Apr; 117(1):251-2. PubMed ID: 11918566
[No Abstract] [Full Text] [Related]
36. Is ADAMTS-13 deficiency specific for thrombotic thrombocytopenic purpura? No.
Remuzzi G
J Thromb Haemost; 2003 Apr; 1(4):632-4. PubMed ID: 12871391
[No Abstract] [Full Text] [Related]
37. Plasma therapy in thrombotic thrombocytopenic purpura: review of the literature and the Bern experience in a subgroup of patients with severe acquired ADAMTS-13 deficiency.
Fontana S; Kremer Hovinga JA; Studt JD; Alberio L; Lämmle B; Taleghani BM
Semin Hematol; 2004 Jan; 41(1):48-59. PubMed ID: 14727259
[TBL] [Abstract][Full Text] [Related]
38. Management of cancer-associated thrombotic microangiopathy: what is the right approach?
Werner TL; Agarwal N; Carney HM; Rodgers GM
Am J Hematol; 2007 Apr; 82(4):295-8. PubMed ID: 17034030
[TBL] [Abstract][Full Text] [Related]
39. [Idiopathic thrombotic thrombocytopenic purpura or Moschowitz syndrome: current physiopathologic and therapeutic perspectives].
Retornaz F; Durand JM; Poullin P; Lefèvre P; Soubeyrand J
Rev Med Interne; 2000 Sep; 21(9):777-84. PubMed ID: 11039173
[TBL] [Abstract][Full Text] [Related]
40. Von Willebrand factor-cleaving protease activity remains at the intermediate level in thrombotic thrombocytopenic purpura.
Sugimoto T; Saigo K; Shin T; Kaneda Y; Manabe N; Narita H; Wakuya J; Imoto S; Murayama T; Matsumoto M; Fujimura Y; Nishimura R; Koizumi T; Kumagai S
Acta Haematol; 2005; 113(3):198-203. PubMed ID: 15870491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
